professional documents
home
Upload
docsters
Upload

search results


FDA Regulations and Recommendations for Failure Investigations

FDADocs 5/5/2008 | 0 (0) | 61 | 1 | 0 | English

FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of  ... more>>

FDA Labeling Supplement Approval Letter

GovernmentDocs 5/5/2008 | 0 (0) | 61 | 0 | 0 | English

NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n...  ... more>>

FDA Clarification of Aripiprazole Tablets Bioequivalence Requirements

GovernmentDocs 5/4/2008 | 0 (0) | 61 | 3 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD 20857September 28, 2006Reference Number: Dear Aripiprazole ANDA Applicant: This letter i...  ... more>>

Vaccine Safety An FDA Perspective PDF KB Presentations

FDADocs 5/9/2008 | 0 (0) | 60 | 0 | 0 | English

Vaccine Safety: An FDA PerspectiveKaren Midthun, M.D. Deputy Director Center for Biologics Evaluation and Research U.S. FDAAmerican Course on Drug Development and Regulatory Sciences Washington  ... more>>

FDA Labeling Supplement Approval Letter Historical Information

FDADocs 5/9/2008 | 0 (0) | 60 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau...  ... more>>

FDA Regulations and Recommendations for Failure Investigations PDF KB Presentations

FDADocs 5/9/2008 | 0 (0) | 59 | 1 | 0 | English

FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of  ... more>>

Initial Recall Mind Map

anonymous 6/19/2008 | 0 (0) | 58 | 5 | 0 | English

Initial Recall Mind Map More FREE Mind maps at http:www.mindmapinspiration.co.uk  ... more>>

Premarket Approval Application Filing Review Guidance for Industry and FDA Staff

GovernmentDocs 5/4/2008 | 0 (0) | 58 | 0 | 0 | English

Guidance for Industry and FDA Staff Premarket Approval Application Filing ReviewDocument issued on: May 1, 2003 This document supersedes PMA Filing Decisions (P90-2), dated May 18, 1990 and PMA  ... more>>

How FDA reviews drug names Medication Errors

FDADocs 5/8/2008 | 0 (0) | 55 | 2 | 0 | English

Safety PageHow FDA reviews drug namesEditors??? note: According to a 1999 Institute of Medicine report, approximately 7,000 deaths occur yearly due to medication errors. To help save lives, the  ... more>>

FDA Backgrounder March a m Session

FDADocs 5/9/2008 | 0 (0) | 55 | 1 | 0 | English

Evaluation of Biotechnology-Derived Pharmaceuticals (July 1997) (http://www.fda.gov/cder/guidance  ... more>>

Hearltland recall notice

GovernmentDocs 5/4/2008 | 0 (0) | 54 | 0 | 0 | English

URGENT: DRUG RECALLHRS Lot All lot numbers beginning with the letter ???K??? Example K... lot number beginning with ???K???. The specific products and lot numbers subject to this recall can  ... more>>

Med error reports to FDA show a mixed bag Medication Errors

FDADocs 5/8/2008 | 0 (0) | 54 | 0 | 0 | English

Safety PageTable 1.Med error reports to FDA show a mixed baghe medication errors staff in... Adverse Event Reporting System (AERS) database for all cases of medication errors. Since the FDA often  ... more>>

FDA FY Congressional Justifications Online Performance Appendix

GovernmentDocs 5/4/2008 | 0 (0) | 53 | 0 | 0 | English

FDA???s FY 2009 Congressional Justifications Online Performance Appendix January 30, 2008Introduction The Online Performance Appendix is one of several documents that fulfill the Department of  ... more>>

Draft FDA NTP Studies of Insertional Mutagensis Pilot Study

FDADocs 5/9/2008 | 0 (0) | 53 | 0 | 0 | English

Rec???d from Rick Irwin 12/22/05/updated to include comments LR 01.02.06FDA-NTP Studies of Insertional Mutagenesis: Pilot Study Revision Date: 01.02.06 Reason for Revision: To include comments  ... more>>

FORM FDA RECALL AUDIT CHECK REPORT

FDADocs 5/9/2008 | 0 (0) | 52 | 0 | 0 | English

1. RECALL INFORMATION a. RECALL NUMBER b. RECALLING ESTABLISHMENT2. PROGRAM DATA (CHECK BOX IF PREVIOUSLY SUBMITTED) (DO NOT COMPLETE IF REPORTED UNDER FDA 2123) a. ACCOMP DISTRICT CODE b. HOME  ... more>>


   
  results / page   15/25/50 Page: 4 of 33 << prev 1234567...33 next >>